Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model

Takafumi Toyohara, Takehiro Suzuki, Yasutoshi Akiyama, Daisuke Yoshihara, Yoichi Takeuchi, Eikan Mishima, Koichi Kikuchi, Chitose Suzuki, Masayuki Tanemoto, Sadayoshi Ito, Shizuko Nagao, Tomoyoshi Soga, Takaaki Abe

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited systemic disease characterized by renal cyst expansion, resulting in renal failure. With the progression of renal damage, the accumulation of uremic compounds is recently reported to subsequently cause further renal damage and hypertension. Finding uremic toxins and sensitive markers for detecting the early stage of ADPKD is necessary to clarify its pathophysiological process and to prevent its progression. The aim of this study was to analyze the profile of uremic retention solutes of ADPKD by capillary electrophoresis-mass spectrometry (CE-MS) using the Han:SPRD rat model. Methods: Two hundred and ninety-seven cations and 190 anions were comprehensively analyzed by CE-MS in Han:SPRD rats and control rats. Results: We found 21 cations and 19 anions that accumulated significantly in the heterozygous (Cy/+) ADPKD rat model compared with control rats. Among the compounds, increases in 5-methyl-2′-deoxycytidine, glucosamine, ectoine, allantoate, α-hydroxybenzoate, phenaceturate and 3-phenylpropionate and decreases in 2-deoxycytidine, decanoate and 10-hydroxydecanoate were newly identified in the ADPKD Cy/+ rats. Conclusion: We identified uremic retention solutes in ADPKD Cy/+ rats. Compounds related to ADPKD could be useful markers for detecting the early stage of ADPKD.

Original languageEnglish
Pages (from-to)676-687
Number of pages12
JournalClinical and Experimental Nephrology
Volume15
Issue number5
DOIs
Publication statusPublished - 2011 Oct

Fingerprint

Autosomal Dominant Polycystic Kidney
Metabolomics
5-methyldeoxycytidine
Capillary Electrophoresis
Anions
Cations
Mass Spectrometry
Decanoates
Kidney
Hydroxybenzoates
Deoxycytidine
Renal Hypertension
Glucosamine
Renal Insufficiency
Cysts

Keywords

  • ADPKD
  • Biomarker
  • CE-MS
  • Uremic toxin

ASJC Scopus subject areas

  • Nephrology
  • Physiology
  • Physiology (medical)

Cite this

Toyohara, T., Suzuki, T., Akiyama, Y., Yoshihara, D., Takeuchi, Y., Mishima, E., ... Abe, T. (2011). Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. Clinical and Experimental Nephrology, 15(5), 676-687. https://doi.org/10.1007/s10157-011-0467-4

Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. / Toyohara, Takafumi; Suzuki, Takehiro; Akiyama, Yasutoshi; Yoshihara, Daisuke; Takeuchi, Yoichi; Mishima, Eikan; Kikuchi, Koichi; Suzuki, Chitose; Tanemoto, Masayuki; Ito, Sadayoshi; Nagao, Shizuko; Soga, Tomoyoshi; Abe, Takaaki.

In: Clinical and Experimental Nephrology, Vol. 15, No. 5, 10.2011, p. 676-687.

Research output: Contribution to journalArticle

Toyohara, T, Suzuki, T, Akiyama, Y, Yoshihara, D, Takeuchi, Y, Mishima, E, Kikuchi, K, Suzuki, C, Tanemoto, M, Ito, S, Nagao, S, Soga, T & Abe, T 2011, 'Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model', Clinical and Experimental Nephrology, vol. 15, no. 5, pp. 676-687. https://doi.org/10.1007/s10157-011-0467-4
Toyohara, Takafumi ; Suzuki, Takehiro ; Akiyama, Yasutoshi ; Yoshihara, Daisuke ; Takeuchi, Yoichi ; Mishima, Eikan ; Kikuchi, Koichi ; Suzuki, Chitose ; Tanemoto, Masayuki ; Ito, Sadayoshi ; Nagao, Shizuko ; Soga, Tomoyoshi ; Abe, Takaaki. / Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model. In: Clinical and Experimental Nephrology. 2011 ; Vol. 15, No. 5. pp. 676-687.
@article{d1193fa2de36471dbe23f069953add1b,
title = "Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model",
abstract = "Background: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited systemic disease characterized by renal cyst expansion, resulting in renal failure. With the progression of renal damage, the accumulation of uremic compounds is recently reported to subsequently cause further renal damage and hypertension. Finding uremic toxins and sensitive markers for detecting the early stage of ADPKD is necessary to clarify its pathophysiological process and to prevent its progression. The aim of this study was to analyze the profile of uremic retention solutes of ADPKD by capillary electrophoresis-mass spectrometry (CE-MS) using the Han:SPRD rat model. Methods: Two hundred and ninety-seven cations and 190 anions were comprehensively analyzed by CE-MS in Han:SPRD rats and control rats. Results: We found 21 cations and 19 anions that accumulated significantly in the heterozygous (Cy/+) ADPKD rat model compared with control rats. Among the compounds, increases in 5-methyl-2′-deoxycytidine, glucosamine, ectoine, allantoate, α-hydroxybenzoate, phenaceturate and 3-phenylpropionate and decreases in 2-deoxycytidine, decanoate and 10-hydroxydecanoate were newly identified in the ADPKD Cy/+ rats. Conclusion: We identified uremic retention solutes in ADPKD Cy/+ rats. Compounds related to ADPKD could be useful markers for detecting the early stage of ADPKD.",
keywords = "ADPKD, Biomarker, CE-MS, Uremic toxin",
author = "Takafumi Toyohara and Takehiro Suzuki and Yasutoshi Akiyama and Daisuke Yoshihara and Yoichi Takeuchi and Eikan Mishima and Koichi Kikuchi and Chitose Suzuki and Masayuki Tanemoto and Sadayoshi Ito and Shizuko Nagao and Tomoyoshi Soga and Takaaki Abe",
year = "2011",
month = "10",
doi = "10.1007/s10157-011-0467-4",
language = "English",
volume = "15",
pages = "676--687",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model

AU - Toyohara, Takafumi

AU - Suzuki, Takehiro

AU - Akiyama, Yasutoshi

AU - Yoshihara, Daisuke

AU - Takeuchi, Yoichi

AU - Mishima, Eikan

AU - Kikuchi, Koichi

AU - Suzuki, Chitose

AU - Tanemoto, Masayuki

AU - Ito, Sadayoshi

AU - Nagao, Shizuko

AU - Soga, Tomoyoshi

AU - Abe, Takaaki

PY - 2011/10

Y1 - 2011/10

N2 - Background: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited systemic disease characterized by renal cyst expansion, resulting in renal failure. With the progression of renal damage, the accumulation of uremic compounds is recently reported to subsequently cause further renal damage and hypertension. Finding uremic toxins and sensitive markers for detecting the early stage of ADPKD is necessary to clarify its pathophysiological process and to prevent its progression. The aim of this study was to analyze the profile of uremic retention solutes of ADPKD by capillary electrophoresis-mass spectrometry (CE-MS) using the Han:SPRD rat model. Methods: Two hundred and ninety-seven cations and 190 anions were comprehensively analyzed by CE-MS in Han:SPRD rats and control rats. Results: We found 21 cations and 19 anions that accumulated significantly in the heterozygous (Cy/+) ADPKD rat model compared with control rats. Among the compounds, increases in 5-methyl-2′-deoxycytidine, glucosamine, ectoine, allantoate, α-hydroxybenzoate, phenaceturate and 3-phenylpropionate and decreases in 2-deoxycytidine, decanoate and 10-hydroxydecanoate were newly identified in the ADPKD Cy/+ rats. Conclusion: We identified uremic retention solutes in ADPKD Cy/+ rats. Compounds related to ADPKD could be useful markers for detecting the early stage of ADPKD.

AB - Background: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited systemic disease characterized by renal cyst expansion, resulting in renal failure. With the progression of renal damage, the accumulation of uremic compounds is recently reported to subsequently cause further renal damage and hypertension. Finding uremic toxins and sensitive markers for detecting the early stage of ADPKD is necessary to clarify its pathophysiological process and to prevent its progression. The aim of this study was to analyze the profile of uremic retention solutes of ADPKD by capillary electrophoresis-mass spectrometry (CE-MS) using the Han:SPRD rat model. Methods: Two hundred and ninety-seven cations and 190 anions were comprehensively analyzed by CE-MS in Han:SPRD rats and control rats. Results: We found 21 cations and 19 anions that accumulated significantly in the heterozygous (Cy/+) ADPKD rat model compared with control rats. Among the compounds, increases in 5-methyl-2′-deoxycytidine, glucosamine, ectoine, allantoate, α-hydroxybenzoate, phenaceturate and 3-phenylpropionate and decreases in 2-deoxycytidine, decanoate and 10-hydroxydecanoate were newly identified in the ADPKD Cy/+ rats. Conclusion: We identified uremic retention solutes in ADPKD Cy/+ rats. Compounds related to ADPKD could be useful markers for detecting the early stage of ADPKD.

KW - ADPKD

KW - Biomarker

KW - CE-MS

KW - Uremic toxin

UR - http://www.scopus.com/inward/record.url?scp=80755140060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80755140060&partnerID=8YFLogxK

U2 - 10.1007/s10157-011-0467-4

DO - 10.1007/s10157-011-0467-4

M3 - Article

VL - 15

SP - 676

EP - 687

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 5

ER -